Everyone seems to think that with one approval all the doctors in the world will start aggressively using Leronlimab off label for all sorts of conditions it probably will have a positive effect on. I've popped up in those conversations over the years to say that's wrong. Doctors, in most cases, are really slow to adapt. Some are outright terrible at their jobs and just put their head down and get the day done. But I do think there's going to be a decent opportunity for off label use when it comes to longhaulers. By the time we get our approval I highly doubt there will be anything on the market that's legitimately helping people. And there are a LOT of people. It's going to be easier for a doctor to justify trying something like LL in a longhauler patient than it would be for an off-indication use in something more serious like cancer. It still wouldn't be like wildfire, because doctors don't operate that way, but I can see it catching on.